Acadia Pharmaceuticals reported $-30866000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
ALKERMES ALKS:US USD -60641000 26.18M
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Aptinyx Inc APTX:US USD -14657000 2.45M
Biogen BIIB:US USD 1.32B 1.37B
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bristol Myers Squibb BMY:US USD 2.47B 117M
Cara Therapeutics CARA:US USD -23845000 19.37M
Corcept Therapeutics CORT:US USD 31.93M 502K
Cytokinetics CYTK:US USD -130687000 119.81M
Eisai 4523:JP JPY -2181000000 9.62B
Eli Lilly And LLY:US USD 1.68B 466.4M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
Johnson & Johnson JNJ:US USD 4.2B 1.62B
Marinus Pharmaceuticals MRNS:US USD -30099000 6.67M
Moderna Inc MRNA:US USD 1.17B 1.28B
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Pfizer PFE:US USD 9.41B 2.69B
Prothena PRTA:US USD -50332000 7.12M
Ptc Therapeutics PTCT:US USD -68187000 24.17M
Sarepta Therapeutics SRPT:US USD -256796000 45.66M
Seattle Genetics SGEN:US USD -192805000 59.69M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Vanda Pharmaceuticals VNDA:US USD 3.91M 447K
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M
YTE INCY:US USD 138.38M 116.06M